Terutroban

CAS No. 165538-40-9

Terutroban( S-18886 )

Catalog No. M12526 CAS No. 165538-40-9

Terutroban (S-18886) is a potent, selective antagonist of the thromboxane receptor (Prostanoid TP receptor) that blocks thromboxane induced platelet aggregation and vasoconstriction.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 41 In Stock
10MG 64 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Terutroban
  • Note
    Research use only, not for human use.
  • Brief Description
    Terutroban (S-18886) is a potent, selective antagonist of the thromboxane receptor (Prostanoid TP receptor) that blocks thromboxane induced platelet aggregation and vasoconstriction.
  • Description
    Terutroban (S-18886) is a potent, selective antagonist of the thromboxane receptor (Prostanoid TP receptor) that blocks thromboxane induced platelet aggregation and vasoconstriction.Atherosclerosis Phase 3 Clinical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    S-18886
  • Pathway
    GPCR/G Protein
  • Target
    Prostaglandin Receptor
  • Recptor
    Prostaglandin Receptor
  • Research Area
    Cardiovascular Disease
  • Indication
    Atherosclerosis

Chemical Information

  • CAS Number
    165538-40-9
  • Formula Weight
    407.911
  • Molecular Formula
    C20H22ClNO4S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 22 mg/mL
  • SMILES
    O=C(O)CCC1=C2CC[C@@H](NS(=O)(C3=CC=C(Cl)C=C3)=O)CC2=CC=C1C
  • Chemical Name
    1-Naphthalenepropanoic acid, 6-[[(4-chlorophenyl)sulfonyl]amino]-5,6,7,8-tetrahydro-2-methyl-, (6R)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Gaussem P, et al. J Thromb Haemost. 2005 Jul;3(7):1437-45. 2. Xu S, et al. Diabetes. 2006 Jan;55(1):110-9. 3. Simonet S, et al. Adv Exp Med Biol. 1997;433:173-6.
molnova catalog
related products
  • Grapiprant

    A novel EP4 antagonist; an analgesic and anti-inflammatory drug in the piprant class that was approved for Veterinary Medicine for the control of pain and inflammation.

  • Ginsenoside Re

    Ginsenoside Re may have properties that inhibit or prevent the growth of tumors.

  • Secoxyloganin

    Secoxyloganin possesses a hepato-protective effect. Secoxyloganin possesses antibacterial activity.